Many reported small molecules with proinflammatory cytokine inhibitory activity, such as glucocorticoids, rapamycin or VitD, among others, are also endowed with the ability to promote IL-10 production in vitro and/or in vivo, and to alleviate CID in preclinical models (24, 28, 29). The gene discussed is IL10; the disease is combined immunodeficiency.